In situ targeting of dendritic cells by antigen-loaded red blood cells: A novel approach to cancer immunotherapy

Vaccine

Volumn 28, Issue 17, 2010, Pages 2965-2972

  Banz, Alice ^a   Cremel, Magali ^a   Rembert, Audrey ^a   Godfrin, Yann ^a  

^a ERYTECH PHARMA   (France)

Author keywords

Antigen delivery system; Cytotoxic T lymphocytes; Red blood cells

Indexed keywords

OVALBUMIN; POLYINOSINIC POLYCYTIDYLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; ERYTHROCYTE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, NEOPLASM; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; ERYTHROCYTES; IMMUNOTHERAPY; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASMS; OVALBUMIN; PHAGOCYTOSIS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77949657392     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.02.013     Document Type: Article

References (26)

1. Renno T., Lebecque S., Renard N., Saeland S., and Vicari A. What's new in the field of cancer vaccines?. Cell Mol Life Sci 60 7 (2003) 1296-1310
2. Melief C.J. Cancer immunotherapy by dendritic cells. Immunity 29 3 (2008) 372-383
3. Banchereau J., Schuler-Thurner B., Palucka A.K., and Schuler G. Dendritic cells as vectors for therapy. Cell 106 3 (2001) 271-274
4. Tacken P.J., de Vries I.J., Torensma R., and Figdor C.G. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat Rev Immunol 7 10 (2007) 790-802
5. + T cell tolerance. J Exp Med 196 12 (2002) 1627-1638
6. Felnerova D., Viret J.-F., Gluck R., and Moser C. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs. Curr Opin Biotechnol 15 (2004) 518-529
7. Hamidi M., and Tajerzadeh H. Carrier RBCs: an overview. Drug Deliv 10 1 (2003) 9-20
8. Hamidi M., Zarrin A., Foroozesh M., and Mohammadi-Samani S. Applications of carrier RBCs in delivery of biopharmaceuticals. J Control Release 118 2 (2007) 145-160
9. Ing R., Segura M., Thawani N., Tam M., and Stevenson M.M. Interaction of mouse dendritic cells and malaria-infected RBCs: uptake, maturation, and antigen presentation. J Immunol 176 January (1) (2006) 441-450
10. Zimring J.C., Hair G.A., Deshpande S.S., and Horan J.T. Immunization to minor histocompatibility antigens on transfused RBCs through crosspriming into recipient MHC class I pathways. Blood 107 1 (2006) 187-189
11. Murray A.M., Pearson I.F., Fairbanks L.D., Chalmers R.A., Bain M.D., and Bax B.E. The mouse immune response to carrier erythrocyte entrapped antigens. Vaccine 24 35-36 (2006) 6129-6139
12. Dominici S., Laguardia M.E., Serafini G., Chiarantini L., Fiorelli V., Gavioli R., et al. Red blood cell-mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat neutralizing antibodies and CTL. Vaccine 21 17-18 (2003) 2073-2081
13. Corinti S., Chiarantini L., Dominici S., Laguardia M.E., Magnani M., and Girolomoni G. RBCs deliver Tat to interferon-gamma-treated human dendritic cells for efficient initiation of specific type 1 immune responses in vitro. J Leukoc Biol 71 4 (2002) 652-658
14. Boberg A., Dominici S., Brave A., Hallermalm K., Hinkula J., Magnani M., et al. Immunization with HIV protease peptides linked to syngeneic RBCs. Infect Agent Cancer 2 (2007) 9
15. Blakney G.B., and Dinwoodie A.J. A spectrophotometric scanning technique for the rapid determination of plasma hemoglobin. Clin Biochem 8 2 (1975) 96-102
16. Hamidi M., Zarei N., Zarrin A.H., and Mohammadi-Samani S. Preparation and in vitro characterization of carrier RBCs for vaccine delivery. Int J Pharm 338 1-2 (2007) 70-78
17. Hamidi M., Zarei N., Zarrin A.H., and Mohammadi-Samani S. Preparation and validation of carrier human RBCs loaded by bovine serum albumin as a model antigen/protein. Drug Deliv 14 5 (2007) 295-300
18. Regnault A., Lankar D., Lacabanne V., Rodriguez A., Théry C., Rescigno M., et al. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med 189 2 (1999) 371-380
19. Johansen P., Storni T., Rettig L., Qiu Z., Der-Sarkissian A., Smith K.A., et al. Antigen kinetics determines immune reactivity. Proc Natl Acad Sci USA 105 13 (2008) 5189-5194
20. den Brok M.H., Nierkens S., Figdor C.G., Ruers T.J., and Adema G.J. Dendritic cells: tools and targets for antitumor vaccination. Expert Rev Vaccines 4 5 (2005) 699-710
21. + T-cell help. Blood 109 12 (2007) 5318-5326
22. Hendrickson J.E., Chadwick T.E., Roback J.D., Hillyer C.D., and Zimring J.C. Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood 110 7 (2007) 2736-2743
23. Heath W.R., Belz G.T., Behrens G.M., Smith C.M., Forehan S.P., and Parish I.A. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 199 (2004) 9-26
24. Guermonprez P., Saveanu L., Kleijmeer M., Davoust J., Van Endert P., and Amigorena S. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425 6956 (2003) 397-402
25. Wilson N.S., Behrens G.M.N., Lundie R.J., Smith C.M., Waithman J., Young L., et al. Systemic activation of dendritic cells by Toll-like receptor ligands and malaria infection impairs cross-presentation and anti-viral immunity. Nat Immunol (2006) 165-172
26. Blander J.M., and Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 404 (2006) 808-812